BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

This test employs Droplet Digital PCP (ddPCR) technology to analyze POLE gene mutations in endometrial cancer patients, facilitating the detection of genet...

October 12, 2023 | News

Monash University Sets Australian Standard with Groundbreaking Diabetes Precision Medicine Report.

In a significant development, a new international consensus report on precision medicine in diabetes prevention and care has been released in the renowned ...

October 11, 2023 | News

LGC Acquires Virusys Corp, Expanding Infectious Disease Portfolio

Virusys’ monoclonal antibody technologies and virology expertise are highly complementary to LGC Clinical Diagnostics’ existing antigen product...

October 10, 2023 | News

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...

October 10, 2023 | News

Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments

Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for dis...

October 06, 2023 | News

Promega & GSK to Create MSI Companion Diagnostic IVD Kit

Promega Corporation today announced it plans to develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit with G...

October 05, 2023 | News

FDA Clears Transcenta for Global Phase III Trial of Osemitamab in Gastric Cancer

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

October 04, 2023 | News

ZEISS and Boehringer Ingelheim Collaborate on Early Eye Disease Detection to Prevent Vision Loss.

The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...

October 03, 2023 | News

Bausch + Lomb Completes Acquisition of XIIDRA®

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced it h...

October 02, 2023 | News

PHC and JCR Pharma Release Second Update for "Meron Diary" Growth Hormone Treatment App

Jointly developed by PHC IVD and JCR Pharma and released for the first time in October 2020, "Meron Diary" is a smartphone application that can wirelessly ...

October 02, 2023 | News

Rimegepant Now Available in Hong Kong as First Asian Market for Migraine Management

"As the first market in Asia, we are pleased to bring to Hong Kong this medication for migraine, as we understand how migraine can adversely...

October 02, 2023 | News

BioCity and AstraZeneca Collaborate on Hepatocellular Carcinoma Treatment in China

BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...

September 28, 2023 | News

Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design

Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...

September 27, 2023 | News

Bayer Indonesia launches "Bayer For Her" to improve the reproductive health of Indonesian women English

Coinciding with the commemoration of World Contraception Day 2023, Bayer Indonesia launched the "Bayer for Her" campaign, underscoring the i...

September 27, 2023 | News

Stay Connected